Education
About Us
Working with TipRanks
Follow Us
Nanologica AB (DE:4YD)
:4YD
4YD Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.05 - €0.51
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€8.42M
Enterprise Value€93.32M
Total Cash (Recent Filing)kr28.35M
Total Debt (Recent Filing)kr7.24M
Price to Earnings (P/E)―
Beta0.77
Next Earnings
Jul 11, 2025EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding88,357,230
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)164.12
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Nanologica AB News
---
4YD FAQ
What was Nanologica AB’s price range in the past 12 months?
Nanologica AB lowest stock price was €0.04 and its highest was €0.51 in the past 12 months.
What is Nanologica AB’s market cap?
Nanologica AB’s market cap is €8.42M.
When is Nanologica AB’s upcoming earnings report date?
Nanologica AB’s upcoming earnings report date is Jul 11, 2025 which is in 74 days.
How were Nanologica AB’s earnings last quarter?
Nanologica AB released its earnings results on Apr 17, 2025. The company reported -€0.011 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.011.
Is Nanologica AB overvalued?
According to Wall Street analysts Nanologica AB’s price is currently Overvalued.
Does Nanologica AB pay dividends?
Nanologica AB does not currently pay dividends.
What is Nanologica AB’s EPS estimate?
Nanologica AB’s EPS estimate is >-0.01.
How many shares outstanding does Nanologica AB have?
Nanologica AB has 88,357,230 shares outstanding.
What happened to Nanologica AB’s price movement after its last earnings report?
Nanologica AB reported an EPS of -€0.011 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -25%.
Which hedge fund is a major shareholder of Nanologica AB?
Currently, no hedge funds are holding shares in DE:4YD
---
Company Description
Nanologica AB
Nanologica AB develops and manufactures nanoporous silica particles for life science applications. It focuses on two areas: Drug Development and Chromatography. The company's drug delivery platforms are NLAB Spiro and NLAB Silica, which aim to produce better medicines for the benefit of patients. Its geographical segments are Sweden, China, the United States, and the Rest of the world.
---
Technical Analysis
Biosergen AB
―
Active Biotech AB
―
Spago Nanomedical AB
―
Bio-Works Technologies AB
―
---